Make money with your poop? It's totally possible! Find out all the details on how you can turn your poop into cash.

Acurx Pharmaceuticals Inc (ACXP) progresses with phase 3 trials for Ibezapolstat while navigating financial hurdles and seeking strategic partnerships.

Q4 2024 Earnings Call Transcript March 18, 2025 Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter ...

C. difficile can overgrow when the balance of ... a medical procedure where bacteria from a healthy donor's stool is transferred to a patient's gastrointestinal tract to restore balance to the ...

B.C. A statement from the RCMP says officers were able to determine that the ambulance, with two paramedics and one patient onboard, was travelling northbound Tuesday morning when it was struck ...

A new UConn study reveals that tagatose, a plant-based sugar alternative, shows promise in mitigating Clostridioides difficile (C. difficile) infection, particularly those resistant to antibiotics.

The stubborn superbug known as C diff (Clostridioides difficile) if often picked up by patients in hospitals. The fight against C diff takes its toll internally, including a significant disruption of ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

C. difficile caused almost half a million infections in the United States in 2011, and an estimated 83,000 of the patients had at least one recurrence. Approximately 29,000 died within 30 days after ...

Locally, Kaiser Permanente’s Walnut Creek and Antioch Medical Centers have been treating C. diff patients with fecal transplants for the past year. Stanford Hospital and UCSF will also soon ...